Join to View Full Profile
1275 York Ave# C-505New York, NY 10065
Phone+1 212-639-6338
Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins University School of MedicineSelective Pathology, 2009 - 2010
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2005 - 2009
Johns Hopkins School of MedicinePhD, Pharmacology and Molecular Sciences, 1998 - 2004
Peking Union Medical CollegeClass of 1998
Certifications & Licensure
NJ State Medical License 2021 - 2025
NY State Medical License 2008 - 2025
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94].Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, Maria I Carlo, Andrea Knezevic
European Urology. 2025-01-01 - Surgical Outcomes and Genomic Insights of Nonclear Cell Renal Cell Carcinoma With Synchronous and Metachronous Nodal Disease.Lennert Eismann, Mark Zucker, Mark T Dawidek, Stephen W Reese, Lina Posada Calderon
Urology Practice. 2024-09-01 - 5 citationsCabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial.Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, Maria I Carlo, Andrea Knezevic
European Urology. 2024-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
